Titan Pharmaceuticals
TTNP
#10383
Rank
NZ$10.44 M
Marketcap
NZ$7.85
Share price
-3.76%
Change (1 day)
15.06%
Change (1 year)

Market capitalization of Titan Pharmaceuticals (TTNP)

Last known market cap: NZ$10.44 Million

As of March 2026 Titan Pharmaceuticals has a market cap of NZ$10.44 Million. This makes Titan Pharmaceuticals the world's 10383th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Titan Pharmaceuticals from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$10.44 M-1.38%
2025NZ$10.58 M85.56%
2024NZ$5.7 M-41.94%
2023NZ$9.82 M-45.54%
2022NZ$18.04 M21.88%
2021NZ$14.8 M-51.17%
2020NZ$30.32 M83.36%
2019NZ$16.53 M-36.28%
2018NZ$25.95 M-34.4%
2017NZ$39.55 M-67.68%
2016NZ$0.12 B-5.93%
2015NZ$0.13 B100.64%
2014NZ$64.85 M-0.78%
2013NZ$65.37 M-35%
2012NZ$0.10 B15.95%
2011NZ$86.74 M-5.08%
2010NZ$91.38 M-50.7%
2009NZ$0.18 B8289.28%
2008NZ$2.2 M-97.76%
2007NZ$98.65 M-46.2%
2006NZ$0.18 B169.4%
2005NZ$68.06 M-53.3%
2004NZ$0.14 B12.38%
2003NZ$0.12 B71.73%
2002NZ$75.52 M-88.44%
2001NZ$0.65 B-68.5%
2000NZ$2.07 B270.87%
1999NZ$0.55 B489.92%
1998NZ$94.77 M-25.09%
1997NZ$0.12 B-12.62%
1996NZ$0.14 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$975.06 B 9,337,092.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$487.81 B 4,671,197.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
NZ$0.86 B 8,160.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$11.28 B 107,934.78%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
NZ$0.11 B 1,015.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$3.40 B 32,497.26%๐Ÿ‡บ๐Ÿ‡ธ USA